Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KMTS Kestra Medical Technologies Inc

盘前交易 10-29 04:51:10 EDT

29.87

-0.12

-0.40%

最高31.02	最低29.49	成交量53.84万
今开29.59	昨收29.99	日振幅5.09%
总市值17.79亿	流通市值9.18亿	总股本5,956万
成交额1,627万	换手率1.75%	流通股本3,074万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KMTS","market":"US","secType":"STK","nameCN":"Kestra Medical Technologies Inc","latestPrice":29.87,"timestamp":1793217600000,"preClose":29.99,"halted":0,"volume":538412,"delay":0,"changeRate":-0.0040013337779258905,"floatShares":30737300,"shares":59561800,"eps":-2.676295,"marketStatus":"盘前交易","change":-0.12,"latestTime":"10-29 04:51:10 EDT","open":29.59,"high":31.015,"low":29.49,"amount":16270688.958888,"amplitude":0.05085,"askPrice":30.5,"askSize":128,"bidPrice":21.07,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-2.676295,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793280600000},"marketStatusCode":1,"adr":0,"listingDate":1741237200000,"exchange":"NASDAQ","adjPreClose":29.87,"postHourTrading":{"tag":"盘后","latestPrice":29.87,"preClose":29.87,"latestTime":"19:30 EDT","volume":35490,"amount":1060720.729147,"timestamp":1793230202332,"change":0,"changeRate":0,"amplitude":0.031652},"volumeRatio":1.0378394297457627},"requestUrl":"/m/hq/s/KMTS","defaultTab":"news","newsList":[{"id":"1129672175","title":"财报前瞻｜Kestra Medical Technologies Inc本季度营收预计增62.29%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1129672175","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129672175?lang=zh_cn&edition=full","pubTime":"2026-09-07 23:55","pubTimestamp":1788796555,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc将于2026年09月14日发布最新财报。市场一致预期本季度营收为29,007,380.00美元，同比增长62.29%；毛利率为54.76%；净利率暂无一致口径预测；调整后每股收益为-0.62美元，同比增长18.61%。公司当前主营业务亮点在于Medical Products业务支撑全部收入且毛利率维持在50%以上。发展前景最大的现有业务仍为Medical Products，上一季度该业务实现收入95,126,000.00美元，同比增速较高。近期针对Kestra Medical Technologies Inc的分析师评论显示，观点以偏谨慎为主，关注点集中在亏损收窄的可持续性与费用率控制的弹性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Kestra Medical Technologies Inc本季度营收预计增62.29%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181471242","title":"JP摩根首次覆盖Kestra Medical Technologies，给予“增持”评级，目标价30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181471242","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181471242?lang=zh_cn&edition=full","pubTime":"2026-08-10 12:52","pubTimestamp":1786337528,"startTime":"0","endTime":"0","summary":"JP摩根日前正式启动对Kestra Medical Technologies Inc（股票代码：KMTS）的覆盖。该机构给予该股“增持”评级，并将目标价设定为每股30美元。这一举措，无疑为市场释放了积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114576024","title":"Kestra Medical Technologies Inc 第四季度每股亏损0.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114576024","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114576024?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:14","pubTimestamp":1784060072,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc 公布其第四季度运营数据，显示其运营收入为亏损3934.4万美元。\n","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133337444","title":"Kestra Medical Technologies 获定期贷款，提供48个月仅付息期，达成营收里程碑可再延12个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1133337444","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133337444?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:08","pubTimestamp":1784059711,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc 成功获得一笔定期贷款，其条款设计颇具吸引力。根据协议，该公司在贷款的前48个月内仅需支付利息，本金偿付得以暂缓。更值得注意的是，若Kestra Medical Technologies Inc能达成特定的营收里程碑，此仅付息期还可额外延长12个月。这一融资安排为公司的运营和发展提供了显著的财务灵活性，有助于其专注于业务增长与市场拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161915055","title":"Kestra Medical Technologies Inc 第四季度调整后EBITDA为负2,670万美元，逊于市场预期负2,250万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161915055","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161915055?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:02","pubTimestamp":1784059340,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc最新公布的第四季度业绩数据显示，其调整后EBITDA为负2,670万美元。这一结果未能达到市场分析师的普遍预期。此前，IBES的预估值为负2,250万美元。两者之间的差距凸显了该公司在当季面临的财务挑战。此次数据不及预期，可能引发市场对其成本控制、收入增长或运营效率的进一步关注。尽管面临季度亏损，公司的长期发展前景仍需结合其产品管线进展、市场渗透率及行业整体趋势进行综合判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130039825","title":"财报前瞻｜Kestra Medical Technologies Inc本季度营收预计增长68.10%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1130039825","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130039825?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:27","pubTimestamp":1783384036,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc将于2026年07月14日发布新财季业绩，市场关注收入增长与亏损收窄节奏及费用投放节律。Kestra Medical Technologies Inc上季度实现营收2,455.20万美金，毛利率52.57%，归属于母公司股东的净利润为-3,416.60万美金，调整后每股收益-0.61美元。根据近期公开渠道的分析师与机构观点，市场倾向于审慎看待Kestra Medical Technologies Inc的盈利修复路径，看空与中性偏保守观点占比较高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Kestra Medical Technologies Inc本季度营收预计增长68.10%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517174835","title":"可穿戴心脏设备制造商Kestra Medical(KMTS.US)IPO定价17美元/股 上市首日涨逾28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517174835?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:02","pubTimestamp":1741334561,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，可穿戴心脏设备制造商Kestra Medical Technologies以每股17美元的价格发行1190万股股票，高于14 - 16美元的发行价区间，筹资2.02亿美元。Kestra于3月6日(周四)登陆纳斯达克，上市首日收涨28.47%。Kestra正在商业化其心脏康复系统平台，这是一个综合且先进的系统，将监测、治疗、数字健康和患者支持服务整合为一个统一的解决方案。截至2025年1月31日，Kestra的系统已被美国550多家医院积极采用，自2022年8月全面商业化以来，已有超过1.7万名患者使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KMTS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kestramedical.com","stockEarnings":[{"period":"1week","weight":0.0937},{"period":"1month","weight":0.0619},{"period":"3month","weight":0.2903},{"period":"6month","weight":0.3689},{"period":"1year","weight":0.0687},{"period":"ytd","weight":0.1263}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kestra Medical Technologies, Ltd.是一家于2021年5月20日根据百慕大法律注册成立的豁免股份有限公司。该公司是一家商业阶段、可穿戴医疗设备和数字医疗保健公司，专注于使用直观、智能和互联的监测和治疗干预技术改变心血管疾病患者的预后。该公司已经开发并正在商业化他们的心脏恢复系统平台，这是一个综合和先进的系统，将监测、治疗、数字健康和患者支持服务整合为一个单一、统一的解决方案。","exchange":"NASDAQ","name":"Kestra Medical Technologies Inc","nameEN":"Kestra Medical Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kestra Medical Technologies Inc(KMTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kestra Medical Technologies Inc,KMTS,Kestra Medical Technologies Inc股票,Kestra Medical Technologies Inc股票老虎,Kestra Medical Technologies Inc股票老虎国际,Kestra Medical Technologies Inc行情,Kestra Medical Technologies Inc股票行情,Kestra Medical Technologies Inc股价,Kestra Medical Technologies Inc股市,Kestra Medical Technologies Inc股票价格,Kestra Medical Technologies Inc股票交易,Kestra Medical Technologies Inc股票购买,Kestra Medical Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kestra Medical Technologies Inc(KMTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}